Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Contribution of Chronic Obstructive Pulmonary Disease to the Development of Lung Cancer
EF 2016-17
Résumé
Lung cancer is the leading cause of cancer-related death worldwide, with most patients presenting with late-stage disease and a dismal five-year survival rate of 17%. Inflammation is known to be associated with cancer onset and progression, with inflammatory lung diseases such as chronic obstructive pulmonary disease (COPD) increasing the risk of lung cancer development. However, the molecular connection between the two diseases is unknown. While cigarette smoking is known to cause both COPD and lung cancer, our preliminary analysis suggests that there are a set of genes, unrelated to smoking, that are commonly altered in both diseases and have known functions in cell cycle progression. One of these genes, PLK4, has been shown to initiate cancer when over-expressed, but only when p53 levels are drastically decreased. p53 is a well-known tumour suppressor gene commonly altered as a result of cigarette smoking. I will examine lung cancers and normal human bronchial epithelial cells, with both wild-type and mutated p53 expression, for tumour-related cellular behaviours, including migration, cell cycle progression, and cell death. I will also examine airway tumour development using inhaled PLK4 in mice both with and without p53 mutations. This work aims to delineate one of the molecular mechanisms responsible for lung cancer development in COPD patients. Additionally, I will explore if this method of cancer development can be therapeutically targeted to prevent the onset of cancer in patients with COPD and other inflammatory diseases.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
367222
Name
Marshall Erin A
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Prcname2
Special Cases - Awards Programs
Projecttitle
Contribution of Chronic Obstructive Pulmonary Disease to the Development of Lung Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
2-Hit; Chronic Obstructive Pulmonary Disease; Lung Cancer; Oncology; Rna Sequencing; Squamous Cell Carcinoma; Stage I; Tumour Initiation
Abstract
Lung cancer is the leading cause of cancer-related death worldwide, with most patients presenting with late-stage disease and a dismal five-year survival rate of 17%. Inflammation is known to be associated with cancer onset and progression, with inflammatory lung diseases such as chronic obstructive pulmonary disease (COPD) increasing the risk of lung cancer development. However, the molecular connection between the two diseases is unknown. While cigarette smoking is known to cause both COPD and lung cancer, our preliminary analysis suggests that there are a set of genes, unrelated to smoking, that are commonly altered in both diseases and have known functions in cell cycle progression. One of these genes, PLK4, has been shown to initiate cancer when over-expressed, but only when p53 levels are drastically decreased. p53 is a well-known tumour suppressor gene commonly altered as a result of cigarette smoking. I will examine lung cancers and normal human bronchial epithelial cells, with both wild-type and mutated p53 expression, for tumour-related cellular behaviours, including migration, cell cycle progression, and cell death. I will also examine airway tumour development using inhaled PLK4 in mice both with and without p53 mutations. This work aims to delineate one of the molecular mechanisms responsible for lung cancer development in COPD patients. Additionally, I will explore if this method of cancer development can be therapeutically targeted to prevent the onset of cancer in patients with COPD and other inflammatory diseases.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Marshall, Erin A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~